Unum Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference

CAMBRIDGE, Mass.--()--Unum Therapeutics, a clinical stage biopharmaceutical company developing a universal cellular immunotherapy to treat multiple cancers, today announced that President and Chief Executive Officer Chuck Wilson will present at the Cowen and Company 37th Annual Health Care Conference on March 6, 2017 at 4:00pm ET. The conference is being held at the Boston Marriott Copley Place in Boston, MA.

About Unum Therapeutics

Unum Therapeutics uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology in combination with tumor-targeting antibodies, which is designed to activate the body’s own immune system to fight cancer. Unum is actively building a pipeline of ACTR programs in which proprietary, tumor-targeting antibodies are armed to improve their therapeutic potential. The Company is headquartered in Cambridge, MA. For more information, visit www.unumrx.com/.

Contacts

Media Contact:
Unum Therapeutics Inc.
Jeff Michaels, +1-617-843-3820
Corporate_Communications@unumrx.com

Contacts

Media Contact:
Unum Therapeutics Inc.
Jeff Michaels, +1-617-843-3820
Corporate_Communications@unumrx.com